Erica D. Pratt, Ph.D.

Affiliations: 
2008-2015 Biomedical Engineering Cornell University, Ithaca, NY, United States 
Area:
liquid biopsy, noninvasive cancer assays, microfluidics, dPCR, post-translational modifications, peptide engineering
Google:
"Erica D. Pratt"
Mean distance: (not calculated yet)
 

Parents

Sign in to add mentor
Brian J. Kirby grad student 2008-2015 Cornell
Laurie L. Parker post-doc 2018-2021 UMN
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Widstrom NE, Perez M, Pratt ED, et al. (2022) Novel Bruton's Tyrosine Kinase (BTK) Substrates for Time-Resolved Luminescence Assays. Acs Chemical Biology. 17: 1328-1333
Jena S, Damayanti NP, Tan J, et al. (2020) Multiplexable fluorescence lifetime imaging (FLIM) probes for Abl and Src-family kinases. Chemical Communications (Cambridge, England)
Antonarakis ES, Tagawa ST, Galletti G, et al. (2017) Randomized, Noncomparative, Phase II Trial of Early Switch From Docetaxel to Cabazitaxel or Vice Versa, With Integrated Biomarker Analysis, in Men With Chemotherapy-Naïve, Metastatic, Castration-Resistant Prostate Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2017724138
Tagawa ST, Galletti G, Antonarakis ES, et al. (2015) Baseline analysis of circulating tumor cell (CTC) enumeration and androgen receptor (AR) localization in men with metastatic castration-resistant prostate cancer (mCRPC) in TAXYNERGY. Journal of Clinical Oncology. 33: 5031-5031
Tagawa S, Galletti G, Antonarakis E, et al. (2015) 2563 Screening and baseline analysis of circulating tumor cell (CTC) counts and androgen receptor (AR) localization with clinical characteristics of men with metastatic castration-resistant prostate cancer (mCRPC) in TAXYNERGY European Journal of Cancer. 51: S498-S499
Pratt ED, Stepansky A, Hicks J, et al. (2014) Single-cell copy number analysis of prostate cancer cells captured with geometrically enhanced differential immunocapture microdevices. Analytical Chemistry. 86: 11013-7
Kirby BJ, Jodari M, Loftus MS, et al. (2012) Functional characterization of circulating tumor cells with a prostate-cancer-specific microfluidic device. Plos One. 7: e35976
Kirby BJ, Jodari M, Loftus MS, et al. (2012) Correction: Functional Characterization of Circulating Tumor Cells with a Prostate-Cancer-Specific Microfluidic Device Plos One. 7
Jodari M, Loftus M, Gleghorn J, et al. (2011) Capture and analysis of prostate cancer circulating tumor cells (CTCS) using geometrically enhanced differential immunocapture (GEDI). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 53
Pratt ED, Huang C, Hawkins BG, et al. (2011) Rare Cell Capture in Microfluidic Devices. Chemical Engineering Science. 66: 1508-1522
See more...